lipidosin
a long-chain acyl-CoA synthetase found in adrenoleukodystrophy target tissues; amino acid sequence in first source
Also Known As:
bgm protein, mouse; bubblegum protein, mouse
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Dufau, Maria L:
1 article
(03/2009)
|
2. | Li, Jie:
1 article
(03/2009)
|
3. | Sheng, Yi:
1 article
(03/2009)
|
4. | Tsai-Morris, Chon-Hwa:
1 article
(03/2009)
|
5. | Adachi, Eijiro:
1 article
(12/2007)
|
6. | Hashimoto, Naohiro:
1 article
(12/2007)
|
7. | Inagawa-Ogashiwa, Masayo:
1 article
(12/2007)
|
8. | Kato, Chieko:
1 article
(12/2007)
|
9. | Moriya-Sato, Ayako:
1 article
(12/2007)
|
10. | Song, Si-Young:
1 article
(12/2007)
|
Related Diseases
1. | Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
12/09/2000
- " Lipidosin is expressed exclusively in mouse brain, adrenal gland, and testis, which are affected by X-ALD. " 12/09/2000
- " Thus, Lipidosin may mediate the link between ALDP dysfunction and the impairment of fatty acid metabolism in X-ALD." 03/01/2009
- " Its mouse/human homologs, lipidosin/bubblegum, have been suggested to participate in X-linked adrenoleukodystrophy (X-ALD), an adreno/neurodegenerative disorder with accumulation of very long chain fatty acids (VLCFA) in tissues and plasma. " 12/01/2007
- " Lipidosin is an 80-kDa protein with long-chain acyl-CoA synthetase activity expressed in the brain, adrenal gland, testis, and ovary, which are selectively damaged in X-linked adrenoleukodystrophy (X-ALD). "
|
2. | Neurodegenerative Diseases (Neurodegenerative Disease)
|
3. | Demyelinating Diseases (Demyelinating Disease)
|
|
Related Drugs and Biologics